Insmed Incorporated Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$1.32 | -$1.18 | -$1.24 |
Q2 2024 | 2 | -$1.32 | -$1.18 | -$1.24 |
Q3 2024 | 3 | -$1.28 | -$1.14 | -$1.20 |
Q4 2024 | 9 | -$1.27 | -$1.05 | -$1.17 |
Q1 2025 | 3 | -$1.32 | -$1.17 | -$1.25 |
Q2 2025 | 2 | -$1.32 | -$1.18 | -$1.25 |
Q3 2025 | 2 | -$1.27 | -$1.13 | -$1.19 |
Q4 2025 | 2 | -$1.18 | -$1.05 | -$1.11 |
Insmed Incorporated Earnings Date And Information
Insmed Incorporated last posted its earnings results on Thursday, October 31st, 2024. The company reported $-1.27 earnings per share for the quarter, missing analysts' consensus estimates of $-1.19 by $0.08. The company had revenue of 93.43 M for the quarter and had revenue of 305.21 M for the year. Insmed Incorporated has generated $-5 earnings per share over the last year ($-5.34 diluted earnings per share) and currently has a price-to-earnings ratio of -14.7. Insmed Incorporated has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Insmed Incorporated Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/31/2024 | Q3 2024 | -$1.19 | -$1.27 | -0.08 | $93.36 M | $93.43 M |
08/08/2024 | Q2 2024 | -$1.24 | -$1.94 | -0.7 | $87.95 M | $90.34 M |
05/09/2024 | Q1 2024 | -$1.24 | -$1.06 | 0.18 | $75.50 M | |
02/22/2024 | Q4 2023 | -$1.13 | -$1.28 | -0.15 | $83.69 M | |
10/26/2023 | Q3 2023 | -$1.06 | -$1.11 | -0.05 | $79.14 M | $79.07 M |
08/03/2023 | Q2 2023 | -$1.10 | -$1.78 | -0.68 | $70.23 M | $77.23 M |
05/04/2023 | Q1 2023 | -$1.08 | -$1.17 | -0.09 | $65.21 M | |
02/23/2023 | Q4 2022 | -$1.00 | -$1.21 | -0.21 | $59.30 M | |
10/27/2022 | Q3 2022 | -$0.89 | -$1.09 | -0.2 | $66.85 M | $67.73 M |
08/04/2022 | Q2 2022 | -$0.89 | -$0.80 | 0.09 | $58.79 M | $65.22 M |
05/05/2022 | Q1 2022 | -$0.91 | -$0.80 | 0.11 | $53.11 M | |
02/17/2022 | Q4 2021 | -$0.89 | -$0.95 | -0.06 | $56.12 M | |
10/28/2021 | Q3 2021 | -$0.83 | -$0.96 | -0.13 | $48.22 M | $46.76 M |
08/05/2021 | Q2 2021 | -$0.85 | -$1.07 | -0.22 | $43.72 M | $45.37 M |
05/06/2021 | Q1 2021 | -$0.91 | -$0.89 | 0.02 | $40.21 M | |
02/25/2021 | Q4 2020 | -$0.67 | -$1.00 | -0.33 | $41.42 M | |
10/29/2020 | Q3 2020 | -$0.59 | -$0.63 | -0.04 | $46.07 M | $43.64 M |
08/06/2020 | Q2 2020 | -$0.58 | -$0.64 | -0.06 | $34.51 M | $42.50 M |
04/30/2020 | Q1 2020 | -$0.67 | -$0.74 | -0.07 | $36.86 M | |
02/25/2020 | Q4 2019 | -$0.58 | -$0.59 | -0.01 | $45.71 M |
Insmed Incorporated Earnings: Frequently Asked Questions
-
When is Insmed Incorporated's earnings date?
Insmed Incorporated has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
How can I listen to Insmed Incorporated's earnings conference call?
The conference call for Insmed Incorporated's latest earnings report can be listened to online.
-
How can I read Insmed Incorporated's conference call transcript?
The conference call transcript for Insmed Incorporated's latest earnings report can be read online.
-
How much revenue does Insmed Incorporated generate each year?
Insmed Incorporated (:INSM) has a recorded annual revenue of $305.21 M.
-
How much profit does Insmed Incorporated generate each year?
Insmed Incorporated (:INSM) has a recorded net income of $305.21 M. Insmed Incorporated has generated $-5.34 earnings per share over the last four quarters.
-
What is Insmed Incorporated's price-to-earnings ratio?
Insmed Incorporated (:INSM) has a price-to-earnings ratio of -14.7 and price/earnings-to-growth ratio is 4.95.